Claims
- 1. A prostacyclin analog of the formula ##STR1## wherein Y.sub.2 is -C.tbd.C-; wherein Z.sub.2 is ##STR2## wherein Z.sub.1 is (1)-(CH.sub.2).sub.g -CH.sub.2 -CH.sub.2 -, or
- (2)-(CH.sub.2).sub.g -CH.sub.2 -CF.sub.2 -,
- wherein g is the integer zero, one, or 2;
- Wherein M.sub.1 is ##STR3## wherein R.sub.5 is hydrogen or alkyl with one to 4 carbon atoms, inclusive; and
- Wherein L.sub.1 is ##STR4## or a mixture of ##STR5## wherein R.sub.3 and R.sub.4 are hydrogen, methyl, or fluoro, being the same or different, with the proviso that one of R.sub.3 and R.sub.4 is fluoro only when the other is hydrogen or fluoro;
- Wherein L.sub.2 and L.sub.3 are hydrogen or alkyl of one to 4 carbon atoms, inclusive; and
- Wherein R.sub.7 is
- (1)-(CH.sub.2).sub.m -CH.sub.3, ##STR6## WHEREIN M IS THE INTEGER ONE TO 5, INCLUSIVE, H IS THE INTEGER ZERO TO 3, INCLUSIVE; S IS THE INTEGER ZERO, ONE, 2, OR 3, AND T is chloro, fluoro, trifluoromethyl, alkyl of one to 3 carbon atoms, inclusive, or alkoxy of one to 3 carbon atoms, inclusive, with the proviso that not more than two T's are other than alkyl; and the pharmacologically acceptable acid addition salts thereof.
- 2. A prostacyclin analog according to claim 1, wherein Z.sub.2 is a mixture of ##STR7##
- 3. 2-Decarboxy-2-aminomethyl-(6RS)-trans-4,5,13,14-tetradehydro-PGI.sub.1, a prostacyclin analog according to claim 2.
- 4. A prostacyclin analog according to claim 1, wherein Z.sub.2 is ##STR8##
- 5. 2-Decarboxy-2-aminomethyl-trans-4,5,13,14-tetradehydro-6.alpha.-PGI.sub.1, a prostacyclin analog according to claim 4.
- 6. 2-Decarboxy-2-aminomethyl-15-methyl-trans-4,5,13,14-tetradehydro-6.alpha.-PGI.sub.1, a prostacyclin analog according to claim 4.
- 7. 2-Decarboxy-2-aminomethyl-16,16-dimethyl-trans-4,5,13,14-tetradehydro-6.alpha.-PGI.sub.1, a prostacyclin analog according to claim 4.
- 8. 2-Decarboxy-2-aminomethyl-16,16-difluoro-trans-4,5,13,14-tetradehydro-6.alpha.-PGI.sub.1, a prostacyclin analog according to claim 4.
- 9. A prostacyclin analog according to claim 1, wherein Z.sub.2 is ##STR9##
- 10. A prostacyclin analog according to claim 9, wherein Z.sub.1 is -(CH.sub.2).sub.g -CH.sub.2 -CF.sub.2 -.
- 11. 2-Decarboxy-2-aminomethyl-2,2-difluoro-trans-4,5,13,14-tetradehydro-6.beta.-PGI.sub.1, a prostacyclin analog according to claim 10.
- 12. A prostacyclin analog according to claim 9, wherein Z.sub.1 is -(CH.sub.2).sub.g -CH.sub.2 -CH.sub.2 -.
- 13. A prostacyclin analog according to claim 12, wherein g is zero.
- 14. A prostacyclin analog according to claim 13, wherein R.sub.7 is ##STR10##
- 15. 2-Decarboxy-2-aminomethyl-17-phenyl-18,19,20-trinor-trans-4,5,13,14-tetradehydro-6.beta.-PGI.sub.1, a prostacyclin analog according to claim 14.
- 16. A prostacyclin analog according to claim 13, wherein R.sub.7 is ##STR11##
- 17. 2-Decarboxy-2-aminomethyl-16-phenoxy-17,18,19,20-tetranor-trans-4,5,13,14-tetradehydro-6.beta.-PGI.sub.1, a prostacyclin analog according to claim 16.
- 18. A prostacyclin analog according to claim 13, wherein R.sub.7 is -(CH.sub.2).sub.m -CH.sub.3 -.
- 19. A prostacyclin analog according to claim 18, wherein R.sub.5 is methyl.
- 20. 2-Decarboxy-2-aminomethyl-15-methyl-trans-4,5,13,14-tetradehydro-PGI.sub.1, a prostacyclin analog according to claim 19.
- 21. A prostacyclin analog according to claim 18, wherein R.sub.5 is hydrogen.
- 22. A prostacyclin analog according to claim 21, wherein at least one of R.sub.3 and R.sub.4 is fluoro.
- 23. 2-Decarboxy-2-aminomethyl-16,16-difluoro-trans-4,5,13,14-tetradehydro-6.beta.-PGI.sub.1, a prostacyclin analog according to claim 22.
- 24. A prostacyclin analog according to claim 21, wherein at least one of R.sub.3 and R.sub.4 is methyl.
- 25. 2-Decarboxy-2-aminomethyl-16,16-dimethyl-trans-4,5,13,14-tetradehydro-6.beta.-PGI.sub.1, a prostacyclin analog according to claim 24.
- 26. A prostacyclin analog according to claim 21, wherein R.sub.3 and R.sub.4 are both hydrogen.
- 27. 2-Decarboxy-2-aminomethyl-trans-4,5,13,14-tetradehydro-6.beta.-PGI.sub.1, a prostacyclin analog according to claim 26.
CROSS REFERENCE TO RELATED APPLICATION
The present application is a continuation-in-part of Ser. No. 821,536, filed Aug. 3, 1977, now pending.
Non-Patent Literature Citations (1)
Entry |
johnson et al., J.A.C.S., 9:12, Jun. 1977, pp. 4182-4184. |
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
821536 |
Aug 1977 |
|